← SynDRA
FILOREXANT
SynDRA canonical compound SYN0033267 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | HCRTR1 | HCRTR2 |
| Mechanism of action | orexin receptor antagonist |
All known targets
Mechanisms of action (all sources)
- HCRTR2 ANTAGONIST
- Orexin receptor antagonist
- HCRTR1 ANTAGONIST
Cross-references
Synonyms
- MK-6096
- MK 6096
- UNII-E6BTT8VA5Z
- MK6096
- E6BTT8VA5Z
- ((2R,5R)-5-(((5-Fluoropyridin-2-yl)oxy)methyl)-2-methylpiperidin-1-yl)(5-methyl-2-(pyrimidin-2-yl)phenyl)methanone
- Methanone, [(2R,5R)-5-[[(5-fluoro-2-pyridinyl)oxy]methyl]-2-methyl-1-piperidinyl][5-methyl-2-(2-pyrimidinyl)phenyl]-
- Methanone, ((2R,5R)-5-(((5-fluoro-2-pyridinyl)oxy)methyl)-2-methyl-1-piperidinyl)(5-methyl-2-(2-pyrimidinyl)phenyl)-
- Filorexant [USAN:INN]
- Filorexant (USAN)
- Filorexant(mk-6096)
- GTPL4460
- filorexantum
- RefChem:140450
- DTXCID0071255
- MFCD28100674
- Filorexant [USAN]
- FILOREXANT [INN]
- Filorexant (USAN/INN)
- MK-6096; Filorexant
- Filorexant(mk-6096)?
- FILOREXANT [WHO-DD]
- orb1308033
- SCHEMBL1716633
- BDBM104692
- GLXC-10633
- EX-A2101
- AKOS027323764
- CS-4437
- NCGC00484077-01
- AC-35933
- AS-82282
- HY-15653
- US8569311, E-5
- NS00072550
- D10345
- T16096
- F979000
Look up FILOREXANT in the interactive SynDRA portal →